Published : Oct-2019
No. of Pages : 83
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Viscosupplementation Devices Overview
3 Products under Development
3.1 Viscosupplementation Devices - Pipeline Products by Stage of Development
3.2 Viscosupplementation Devices - Pipeline Products by Segment
3.3 Viscosupplementation Devices - Pipeline Products by Territory
3.4 Viscosupplementation Devices - Pipeline Products by Regulatory Path
3.5 Viscosupplementation Devices - Pipeline Products by Estimated Approval Date
3.6 Viscosupplementation Devices - Ongoing Clinical Trials
4 Viscosupplementation Devices - Pipeline Products under Development by Companies
4.1 Viscosupplementation Devices Companies - Pipeline Products by Stage of Development
4.2 Viscosupplementation Devices - Pipeline Products by Stage of Development
5 Viscosupplementation Devices Companies and Product Overview
5.1 Ampio Pharmaceuticals Inc Company Overview
5.2 Anika Therapeutics Inc Company Overview
5.3 Carticept Medical Inc Company Overview
5.4 Chi2Gel Ltd. Company Overview
5.5 Cocoon Biotech, Inc. Company Overview
5.6 Flex Biomedical Inc Company Overview
5.7 Herng Shan Co Ltd Company Overview
5.8 Kalvista Pharmaceuticals Inc Company Overview
5.9 KiOmed Pharma Company Overview
5.10 Lineage Cell Therapeutics Inc Company Overview
5.11 Medytox Inc Company Overview
5.12 Moebius Medical Ltd Company Overview
5.13 OPKO Health Inc Company Overview
5.14 Shin Poong Pharm Co Ltd Company Overview
5.15 University of Kansas Company Overview
6 Viscosupplementation Devices - Recent Developments
6.1 Sep 09, 2019: Bioventus agrees to nationwide contract with UnitedHealthcare commercial plans
6.2 Sep 09, 2019: KalVista Pharmaceuticals reports fiscal first quarter results
6.3 Aug 22, 2019: Ampio Pharmaceuticals retains financial advisor and appoints Transaction Advisory Committee
6.4 Aug 12, 2019: Bioventus launches DUROLANE SJ (1mL) in Australia and New Zealand; receives expanded indications for DUROLANE (3mL)
6.5 Jul 31, 2019: Smith & Nephew second quarter and first half 2019 results
6.6 Jul 24, 2019: Anika reports second quarter 2019 financial results
6.7 Jul 17, 2019: OrthogenRx CEO awarded 2019 Entrepreneur of the Year
6.8 Jul 08, 2019: Anika appoints James Loerop as executive vice president of business development and strategic planning
6.9 May 21, 2019: New U.S. Patents granted for RegenLab
6.10 May 13, 2019: Anika to showcase regenerative medicine and orthobiologics portfolio at the 12th Biennial International Society of Arthroscopy, Knee Surgery and Orthopaedic Sports Medicine Congress
6.11 May 07, 2019: Smith & Nephew: Change of registered office
6.12 May 02, 2019: Smith & Nephew first quarter 2019 trading report
6.13 May 02, 2019: Anika reports first quarter 2019 financial results
6.14 Apr 30, 2019: Anika Therapeutics names Stephen Goldy as vice president of U.S. Sales
6.15 Apr 22, 2019: KalVista Pharmaceuticals names Daniel B. Soland to board of directors
6.16 Apr 03, 2019: Anika to highlight regenerative medicine and Orthobiologics Portfolio at 2019 Asia Pacific Orthopaedic Association Sports Meeting
6.17 Mar 29, 2019: PolarityTE announces Richard Hague, formerly from Sanofi, Genzyme and recently Anika Therapeutics as Chief Operating Officer
6.18 Mar 25, 2019: Smith & Nephew: Re-presented historical quarterly revenue analysis
6.19 Mar 22, 2019: Seikagaku launches HyLink, an intra-articular single-injection viscosupplement for the treatment of knee osteoarthritis in Italy
6.20 Mar 18, 2019: Anika Therapeutics names Robert Richard as Vice President of research and development
6.21 Mar 14, 2019: Kalvista Pharmaceuticals reports fiscal third quarter result
6.22 Mar 06, 2019: Ampio updates regulatory status for Ampion
6.23 Feb 21, 2019: Anika reports fourth quarter and full year 2018 financial results
6.24 Feb 20, 2019: Smith & Nephew celebrates 18th year on FTSE4Good index
6.25 Feb 08, 2019: Smith & Nephew: Directorate changes
6.26 Feb 07, 2019: Smith & Nephew fourth quarter and full year 2018 results
6.27 Feb 06, 2019: Ampio updates status of pivotal clinical trial of Ampion to be carried out under a SPA
6.28 Feb 04, 2019: KYERON receives CE mark approval for
6.29 Feb 01, 2019: KalVista Pharmaceuticals names Brian J. G. Pereira as Board Director
6.30 Jan 29, 2019: Bioventus Launches DUROLANE in Malaysia and Selects Athrotech as Exclusive Distribution Partner
6.31 Dec 14, 2018: KalVista Pharmaceuticals reports fiscal 2018 second quarter results
6.32 Dec 13, 2018: Overland Park Surgical Suites first outpatient surgery center in region to offer robotics-assisted partial and total knee replacement surgery using the Navio surgical system
6.33 Dec 10, 2018: StimLabs announces Department of Veterans Affairs (VA) And Department of Defense (DoD) Agreements
6.34 Nov 01, 2018: Smith & Nephew third quarter 2018 trading report
6.35 Oct 25, 2018: Susan M. Stalnecker named to Bioventus Board of Managers
6.36 Oct 24, 2018: Anika Therapeutics announces Third Quarter 2018 Financial Results
6.37 Oct 24, 2018: Anika Therapeutics names Susan Vogt as Board Director
6.38 Oct 02, 2018: Bioventus Receives ANVISA Approval to Market DUROLANE in Brazil and Selects Pfizer as Exclusive Distribution Partner
7 Appendix
7.1 Methodology
7.2 About GlobalData
7.3 Contact Us
7.4 Disclaimer
List of Tables
Table 1: Viscosupplementation Devices - Pipeline Products by Stage of Development 7
Table 2: Viscosupplementation Devices - Pipeline Products by Segment 8
Table 3: Viscosupplementation Devices - Pipeline Products by Territory 9
Table 4: Viscosupplementation Devices - Pipeline Products by Regulatory Path 10
Table 5: Viscosupplementation Devices - Pipeline Products by Estimated Approval Date 11
Table 6: Viscosupplementation Devices - Ongoing Clinical Trials 12
Table 7: Viscosupplementation Devices Companies - Pipeline Products by Stage of Development 13
Table 8: Viscosupplementation Devices - Pipeline Products by Stage of Development 14
Table 9: Ampio Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview 15
Table 10: Ampion - Product Status 15
Table 11: Ampion - Product Description 15
Table 12: Ampion - Hand Osteoarthritis - Product Status 16
Table 13: Ampion - Hand Osteoarthritis - Product Description 16
Table 14: Ampio Pharmaceuticals Inc - Ongoing Clinical Trials Overview 17
Table 15: Ampion - A Randomized, Controlled, Double-blind Study to Evaluate the Efficacy and Safety of an Intra-articular Injection of Ampion in Adults with Pain Due to Severe Osteoarthritis of the Knee 18
Table 16: Anika Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 19
Table 17: Cingal - Product Status 19
Table 18: Cingal - Product Description 20
Table 19: Hyaluronic Acid - Synovial Joints - Product Status 20
Table 20: Hyaluronic Acid - Synovial Joints - Product Description 20
Table 21: MONOVISC - Hip - Product Status 21
Table 22: MONOVISC - Hip - Product Description 21
Table 23: ORTHOVISC-T - Product Status 21
Table 24: ORTHOVISC-T - Product Description 22
Table 25: Anika Therapeutics Inc - Ongoing Clinical Trials Overview 23
Table 26: Cingal - A Prospective Evaluation of the Cingal Injection for Hip Osteoarthritis (ECHO Study) 24
Table 27: MONOVISC - Hip - Investigational Device Exemption (IDE) Phase III Study of MONOVISC to Treat Pain Caused by Osteoarthritis of the Hip 25
Table 28: ORTHOVISC-T - A Prospective, Open-label, Multi-center Post-market Clinical Follow-up Study to Evaluate the Residual Risk of OrthoVisc-T (OVT) in the Treatment of Chronic Lateral Epicondylosis (Tennis Elbow) 26
Table 29: Carticept Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 27
Table 30: Agilus - Product Status 27
Table 31: Agilus - Product Description 27
Table 32: Chi2Gel Ltd. Pipeline Products & Ongoing Clinical Trials Overview 28
Table 33: Chi2Knee - Product Status 28
Table 34: Chi2Knee - Product Description 28
Table 35: Cocoon Biotech, Inc. Pipeline Products & Ongoing Clinical Trials Overview 29
Table 36: Silk Hydrogel - Product Status 29
Table 37: Silk Hydrogel - Product Description 29
Table 38: Flex Biomedical Inc Pipeline Products & Ongoing Clinical Trials Overview 30
Table 39: Flex Polymer - Product Status 30
Table 40: Flex Polymer - Product Description 30
Table 41: Herng Shan Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 31
Table 42: Hyalease 16 - Product Status 31
Table 43: Hyalease 16 - Product Description 31
Table 44: Hyalease 20 - Product Status 32
Table 45: Hyalease 20 - Product Description 32
Table 46: Hyalease 8 - Product Status 32
Table 47: Hyalease 8 - Product Description 32
Table 48: Kalvista Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview 33
Table 49: ActaVisc - Product Status 33
Table 50: ActaVisc - Product Description 33
Table 51: Hydros - Product Status 34
Table 52: Hydros - Product Description 34
Table 53: Hydros TA - Product Status 34
Table 54: Hydros TA - Product Description 35
Table 55: Hydros TA - Hip - Product Status 35
Table 56: Hydros TA - Hip - Product Description 35
Table 57: KiOmed Pharma Pipeline Products & Ongoing Clinical Trials Overview 36
Table 58: Arthrovisc - Product Status 36
Table 59: Arthrovisc - Product Description 36
Table 60: Lineage Cell Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 37
Table 61: ReGlyde - Product Status 37
Table 62: ReGlyde - Product Description 37
Table 63: Medytox Inc Pipeline Products & Ongoing Clinical Trials Overview 38
Table 64: MT941 - Product Status 38
Table 65: MT941 - Product Description 38
Table 66: Moebius Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 39
Table 67: MM-II - Product Status 39
Table 68: MM-II - Product Description 39
Table 69: OPKO Health Inc Pipeline Products & Ongoing Clinical Trials Overview 40
Table 70: Enko 1 - Product Status 40
Table 71: Enko 1 - Product Description 40
Table 72: Shin Poong Pharm Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 41
Table 73: HyalOne - Product Status 41
Table 74: HyalOne - Product Description 41
Table 75: University of Kansas Pipeline Products & Ongoing Clinical Trials Overview 42
Table 76: 3-D Colloidal Gel - Product Status 42
Table 77: 3-D Colloidal Gel - Product Description 42
Table 78: Glossary 82
List of Figures
Figure 1: Viscosupplementation Devices - Pipeline Products by Stage of Development 7
Figure 2: Viscosupplementation Devices - Pipeline Products by Segment 8
Figure 3: Viscosupplementation Devices - Pipeline Products by Territory 9
Figure 4: Viscosupplementation Devices - Pipeline Products by Regulatory Path 10
Figure 5: Viscosupplementation Devices - Pipeline Products by Estimated Approval Date 11
Figure 6: Viscosupplementation Devices - Ongoing Clinical Trials 12
